Bioventus Inc. Stock Analysis & AI Score
Bioventus Inc. (BVS) has an ST Score of 54.2 (B-), driven by its Profitability (A) and held back by its Growth (D). Analysts rate it Buy with a $18.33 price target (+35.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Bioventus Inc. (BVS) has an ST Score of 54.2 (B-), driven by its Profitability (A) and held back by its Growth (D). Analysts rate it Buy with a $18.33 price target (+35.6% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthD
All factor grades
- ProfitabilityA
- MomentumA
- ForecastB-
- Financial StrengthC-
- ValuationD
- GrowthD
- Piotroski8/9
Contact
BVS stock: frequently asked questions
What is BVS's ST Score?
Bioventus Inc. (BVS) has an ST Score of 54.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BVS a buy, hold, or sell?
Analysts rate BVS a Buy, with a price target of $18.33 (+35.6% vs the current price). Our ST Score grades it B- (54.2/100). The ST Score is a data-driven signal, not a recommendation.
What are BVS's factor grades?
Valuation D, Profitability A, Financial Strength C-, Momentum A, Growth D, Forecast B-.
What is BVS's valuation grade?
Bioventus Inc. (BVS) earns a valuation grade of D, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BVS's growth grade?
Bioventus Inc. (BVS) earns a growth grade of D, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BVS's profitability grade?
Bioventus Inc. (BVS) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BVS's financial strength grade?
Bioventus Inc. (BVS) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BVS?
The average analyst price target for Bioventus Inc. (BVS) is $18.33 from 7 analysts, which is +35.6% versus the recent price of $13.52.
What is BVS's Piotroski score?
Bioventus Inc. (BVS) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.